Sunteți pe pagina 1din 41

Biology of Salmonella

Dr Sophie Helaine

Salmonella pathogenesis

Human diseases
Typhoid (S. enterica Typhi and S. Paratyphi): 17 million cases
and 600,000 deaths/yr - increasing multiple drug resistance
recurrence infection
Non-typhoidal (e.g S. enterica Typhimurium): 1.3 billion
cases and 3 million deaths/yr (major problem in sub-Sarahan
Africa)

Salmonella Typhi and


human typhoid

Typhoid prevalence, 2006

Salmonella Typhi and


human typhoid
Transmission (faecal-oral)

Chronic carrier state


Typhoid Mary

T0

48 h (10 days)

12 days

S. Typhi
Typhimurium

S.

Salmonella pathogenesis
Human diseases
Typhoid (S. enterica Typhi and S. Paratyphi): 17 million cases
and 600,000 deaths/yr - increasing multiple drug resistance
recurrence infection
Non-typhoidal (e.g S. enterica Typhimurium): 1.3 billion
cases and 3 million deaths/yr (major problem in sub-Sarahan
Africa)

Murine model of Typhoid


fever

S. Typhimurium invasion of M cells

Fatal bacteraemia

Colonisation of Peyers
Patches, mesenteric lymph
nodes

Intracellular replication in spleen and liver


macrophages (up to 109 bacterial cells/orga
implies >30 rounds of cell division)

Total number of virulence genes

Estimates suggest approx.


of S. Typhimurium genome
quired for virulence
S. Typhimurium has 4600 ORFs => approx. virulence gene
Approx. genes identified to date
Most are present on Pathogenicity Islands/islets (> 60)
But, biochemical and physiological functions of many
remain unknown

Different virulence genes act at


different stages of S. Typhimurium
virulence
stage of
environmental
infection stimulus

response
genes

stomach

low pH

acid tolerance fur, atr

small
intestine

osmotic stress
anaerobiosis

motility
adhesion
flg, lpf and pef

epithelium
penetration

anaerobiosis
cell contact

invasion

bloodstream

complement
antimicrobial
peptides

macrophage

low pH, low Mg++

virulence

many (e.g.inv/spa)

serum resistance rfb, rfc, rck


peptide resistance sap, htr
complex
many
(pag, SPI-2, spv)

Salmonella an intracellular
pathogen
Salmonella-containing vacuoles in spleen cells

Salmonella an intracellular
pathogen

Listeria
Shigella
Salmonella
Mycobacteria

Coxiella

Intracellular replication in macrophages


(16 h)
wild-type

Dhar and McKinney, Current Opinion in Microbiology 2007

Measuring replication by Fluorescence


Dilution

pDiGc

pDiGi

Helaine et al, PNAS 2010

Measuring replication by Fluorescence


Dilution

18 h
Bone-marrow derived
macrophages

Non-replicating bacteria > 50 %

Helaine et al, PNAS 2010

Bacterial persisters
Many bacterial species form persisters - highly tolerant to antibiotics
Persistent bacterial infections pose significant public-health problems
Typhoid fever in humans - 15% of treated patients suffer a relapse
A major breakthrough was the discovery that E. coli in vitro persisters are nonreplicating bacterial cells (Balaban et al, Science 2004)

Salmonella persisters induced by contact


Persisters are transiently tolerant to AB treatment
with host M
Survival of Salmonella to AB treatment

Interaction with host M, even transient, enhances the formation of


persister cells of Salmonella to 3 different classes of AB

Host induced Salmonella persisters are


Antibiotic tolerant bacteria
: non-lysed by exposure to beta-lactam
non-replicating
100

total intracellular
population
intracellular
persisters

% of Max

80

60

40

21 %

20

9%

0
0

10

10

10
GFP

10

10

Fluorescence
Host induced persisters are non-replicating
bacteria

arabinose-inducible

gfp

104

dsRed

10

+ arabinose

+arabinose

+ triton
103

DsRed
FL2-H

10

DsRed
FL2-H

IPTG-inducible

Non-replicating bacteria
Regrowth

102

101

+ cefotaxime

10

cefotaxime
0

O/N growth

10

10

100

+ IPTG
infect

101

102
FL1-H

103

GFP

Responsive non-replicating
after 24 h in macrophages

- IPTG

10

24 h
in macrophages

104

bacteria

10

10

10
FL1-H

Growth in rich medium

103

103

DsRed

DsRed

104

10

102

10

100
100

102

101

101

102
GFP

103

104

100
100

responding

Proportion of the non-replicating


bacteria resume growth
101

102
GFP

103

104

GFP

regrowing
4

10

Regrowing non-replicating bacteria


after 24 h in macrophages

+ cefotaxime 200 g/mL

10

Non-replicating bacteria
Regrowth
10

10

10

10

DsRed

DsRed

+arabinose

102

10

10

10

24 h
in macrophages

10

10
GFP

10

Responsive persisters after 24 h in IFN


activated C57 macrophages

10

102

10

10

10

10

10
GFP

10

10

Responsive and regrowing persisters in


C57 macrophages

+ cefotaxime 200 g/mL

Figure5

Non replicating bacteria reservoir for relapse of infection

Heterogeneity of intracellular population

Bacterial actors ? Host signals ?

Salmonella pathogenesis
Human diseases
Typhoid (S. enterica Typhi and S. Paratyphi): 17 million cases
and 600,000 deaths/yr - increasing multiple drug resistance
recurrence infection
Non-typhoidal (e.g S. enterica Typhimurium): 1.3 billion
cases and 3 million deaths/yr (major problem in sub-Sarahan
Africa)

Salmonella an intracellular
pathogen
Two T3SS
SPI-1 mediates invasion of host cells
and
intestinal secretory and inflammatory
responses
SPI-2 is required for bacterial replication
and immune modulation

Salmonella an intracellular
pathogen
Two T3SS

Adhesion

Invasion

SPI-1 T3SS
Extracellular

SCV formation

SCV maturation

SPI-2 T3SS
Intracellular

Replication

Salmonella invasion of epithelial


cells occurs
via the
SPI-1
type
III secretion
effectors
induce
actin polymerisation,
membrane ruffling
and bacterial internalisation
system
Effector

Salmonella an intracellular
pathogen
Two T3SS

Adhesion

Invasion

SPI-1 T3SS
Extracellular

SCV formation

SCV maturation

SPI-2 T3SS
Intracellular

Replication

effectors (SifA, SseJ, SseG, etc)

SPI-2 Type III


ecretion system

acidic pH triggers
secretion

translocon pore (SseC, SseD)


vacuolar membrane

H+

H+
translocon (SseB)

H+
H+

H+

H+

H+

secreton needle
bacterial outer
membrane

SsaC
SsaJ

bacterial inner
membrane

SsaV
SsaM
SpiC
SsaL

ssaV mutant
is null for
SPI-2 function

Intracellular replication defect of a SPI-2


null mutant in macrophages (16 h)

wild-type

SPI-2 mutant

Effectors of the SPI-2 T3SS

From Figueira and Holden, Microbiology, 2012

Effectors of the SPI-2 T3SS

From Figueira and Holden, Microbiology, 2012

Effectors of the SPI-2 T3SS

Figueira et al, manuscript in preparation

Salmonella pathogenesis
Human diseases
Typhoid (S. enterica Typhi and S. Paratyphi): 17 million cases
and 600,000 deaths/yr - increasing multiple drug resistance
recurrence infection
Non-typhoidal (e.g S. enterica Typhimurium): 1.3 billion
cases and 3 million deaths/yr (major problem in sub-Sarahan
Africa)

typhoidal Salmonella in HIV-infected African a


NTS (S. Typhimurium and Enteritidis):
Predominantly cause self-limiting gastroenteritis
BUT
major cause of invasive disease in Africa, young
children and HIV-infected adults
Non specific fever (+/- diarrhea) Bacteremia
Case fatalities (22-45 %)
AB resistance
No vaccine

Salmonellae are the commonest cause


of bacterial bloodstream infection in
Africa

(Reddy EA, et al. Lancet Infect Dis 2010)

typhoidal Salmonella in HIV-infected African a

Okoro, et al. Nature Genetics, 2012

typhoidal Salmonella in HIV-infected African a

Log10 change in Salmonella (cfu/ml)

Host resistance to Salmonella relies on:


- cell-mediated immunity (macrophages, PMNs, NK
cells)
- complement killing (induced by Antibodies
OMPs)
HIV-uninfected sera
HIV-infected sera

Exposure to serum (min)

Lack of Ab?

MacLenan, et al. Science, 2010

Log10 change in Salmonella (cfu/ml)

typhoidal Salmonella in HIV-infected African a

HIV-uninfected sera

HIV-infected sera

Total anti- Salmonella IgG titer

MacLenan, et al. Science, 2010

typhoidal Salmonella in HIV-infected African a

Inhibitory factor: LPS IgG

typhoidal Salmonella in HIV-infected African a

Inhibitory factor: LPS IgG

Log10 change in Salmonella (cfu/ml)

typhoidal Salmonella in HIV-infected African a

Exposure to serum (min)

Inhibitory factor: LPS IgG

MacLenan, et al. Science, 2010

Diverting complement deposition away from OM


Impeding access to OM by cross linking O-antigens

Summary

Salmonella enterica different diseases, typhoid and nontyphoidal


Replicates in macrophages in membrane-bound vacuoles
Persists chronic infection, carriers/shedders
SPI-1 and SPI-2 Type III secretion systems are important
virulence components: SPI-1 for invasion and SPI-2 for
replication

More reading
Salmonella takes control: effector driven
manipulation of the host. McGhie et al., Curr
Opinion Microbiol 12: 117 (2009)
Salmonella interplay with host cells: Haraga et al.,
Nature Reviews Microbiol 6: 53 (2008)

S-ar putea să vă placă și